From newly diagnosed patients to aging HIV-positive patients



Launch date: October 28, 2021
Expiry date: October 28, 2022

Supplier’s declaration

This activity is offered jointly by the Postdoctoral Institute of Medicine and Integritas Communications


This activity is in collaboration with the American Academy of HIV Medicine and HealthHIV.


Statement of support

This activity is supported by an educational grant from Gilead Sciences, Inc.

Target audience

This activity is aimed at infectious disease and HIV specialists related to HIV clinical management skills, with the overall program objective of improving the care of patients living with HIV.

educational goals

At the end of this program, the participant should be better able to:

  • Utilize appropriate switching strategies in aging patients with multiple comorbidities considering drug interactions, patient characteristics, patient preference, and risk factors for worsening comorbidities
  • Adapt ART regimens for transgender patients living with HIV to avoid interactions with gender-affirming hormone therapy, accommodate patient preferences, and improve adherence
  • Start ART treatment for all eligible patients as soon as possible after HIV diagnosis

Description of the program

HIV is a rapidly changing field and treatment decisions must be carefully tailored to each patient to improve their outcomes and adherence. To best treat their patients, clinicians need to be familiar with the nuances of ART selection, drug interactions, switching strategies, and how best to care for the whole patient. This activity will examine an elderly patient with common comorbidities, such as cardiovascular disease and depression, a transgender woman who is concerned about interactions between her antiretroviral therapy and gender-affirming hormones and who is unstablely housed, and a newly diagnosed man who uses drugs recreationally. This 3-case simulated patient activity will allow learners to hear patient/clinician interactions, make treatment decisions for the patient, learn what the optimal decisions should be, and review data to support these choices.


Seble G. Kassaye, MD, MS
Associate Professor of Medicine
Department of Medicine
Division of Infectious Diseases
Georgetown University
Washington, District of Columbia


Dr. Seble Kassaye received his medical degree from the Pritzker School of Medicine at the University of Chicago in Illinois before completing his residency in internal medicine and pediatrics at Mount Sinai Medical Center in New York and his fellowship in infectious diseases at Stanford University Hospital in California. She also completed a master’s degree in epidemiology at Stanford University. Dr. Kassaye joined the faculty at Georgetown University in December 2012.
Dr. Kassaye’s research focuses on HIV-related clinical and translational research with the goal of increasing access and uptake of effective HIV treatment and prevention modalities by populations most at risk and most in need. . As the Principal Investigator of the DC MACS/WIHS Combined Cohort Study, she aims to understand how HIV contributes to comorbidities, metabolic and cardiovascular complications, and long-term treatment outcomes, as well as social, psychological and cognition of HIV. Dr. Kassaye has been a practicing physician in Washington, D.C., for nearly a decade, including at an academic tertiary care center as well as a community clinic in the neighborhood with the highest HIV prevalence in the Southeast. from DC. Most of her US-based research projects are driven by issues she identifies in the context of providing care to a very needy and socially vulnerable population.

Sarah E. Rowan, MD
Associate Professor of Medicine
Divisions of Infectious Diseases and Internal Medicine
Associate Director, Supervised Scholarly Activity
University of Colorado School of Medicine
Associate Director of HIV and Viral Hepatitis Prevention
Denver Health
Denver, Colorado

mountain ash

Dr. Sarah Rowan is Associate Director of HIV and Viral Hepatitis Prevention at Denver Public Health and Associate Professor in the Divisions of Infectious Diseases and General Internal Medicine at the University of Colorado Denver. She specializes in the care of patients with HIV, hepatitis C and sexually transmitted infections. Dr. Rowan’s research interests include HIV and Hepatitis C testing, epidemiology and engagement in care, as well as HIV and Hepatitis C health disparities and, more recently, screening for Covid-19. She has led several grant-funded initiatives designed to promote HIV and Hepatitis C testing and treatment. She is also the Associate Director of Public and Community Health for the Mentored Scholarly Activities program at the medical school. from the University of Colorado.

Joint Accreditation Statement

Jointly Accredited SupplierIn order to support the improvement of patient care, this activity was planned and implemented by the Postgraduate Institute of Medicine and Integritas Communications. The Institute of Postgraduate Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC ), to provide ongoing education to the health care team.

Continuing medical education of doctors
The Postgraduate Institute of Medicine designates this live activity for a maximum of 1.25 AMA PRA Tier 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education in Nursing
The maximum number of hours allocated for this continuing nursing education activity is 1.25 contact hours. Pharmacotherapy contact hours for advanced practice registered nurses will be listed on your certificate.

Instructions for receiving credit

In order to receive credit for this activity, the participant must review the activity and successfully complete the post-test and evaluation form.

  • Participants should review all activity information including pre-test, learning objectives, faculty disclosures, simulation scenario(s), and post-activity evaluation .
  • To view the first simulation scenario, launch the simulation from the provided link using a PC, Mac, tablet or phone with a 4G or higher internet connection.
  • Interact appropriately to satisfy each objective to unlock the next objective and view the next simulation scenario.
  • The simulation will track your progress until all scenario objectives are met.
  • Exit the simulation at any time and your progress will be saved so you can come back later to finish.
  • As you complete each scenario (1 minimum, 3 total), you will be eligible for increasing levels of CE credits (ranging from 0.5 to 1.25 credits). Click or tap “Credit” to determine your CE credit status.
  • Once the evaluation is successfully completed, you can download/print a credit certificate immediately via the browser.

Required configuration


Intel Pentium 4 1.4 GHz processor or faster (or equivalent) Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit) 512 MB of RAM (1 GB recommended)

Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox and Google Chrome

For HTML client – Google Chrome (v70.0 and above), Mozilla Firefox (v65.0 and above) and Edge (v42.0 and above)


1.83 GHz or faster Intel Core Duo processor 512 MB of RAM (1 GB recommended) MAC OS X 10.12, 10.13 and 10.14

Mozilla Firefox, Apple Safari, Google Chrome

For HTML client – Google Chrome (v70.0 and above), Apple Safari (v12.0 and above) and Mozilla Firefox (v65.0 and above)

Fee Information and Refund/Cancellation Policy

There is no charge for this educational activity.

Conflict of Interest Disclosure

The Postgraduate Institute of Medicine (PIM) requires professors, planners, and others controlling educational content to disclose all financial relationships with ineligible companies. All conflicts of interest (COI) identified are thoroughly reviewed and mitigated in accordance with the PIM policy. PIM is committed to providing its learners with high quality, accredited continuing education activities and related materials that promote the improvement or quality of healthcare and not a specific commercial interest of an ineligible company.

the Faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this continuing education activity:

Seble G. Kassaye, MD, MS Nothing to disclose
Sarah E. Rowan, MD Nothing to disclose

PIM planners and managers have nothing to disclose. Integritas Communications planners and managers have nothing to disclose.

Unlabeled Use Disclosure

This educational activity may contain discussion of published and/or experimental uses of agents that are not listed by the United States Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of label directions.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to each product’s official prescribing information for a discussion of approved indications, contraindications and warnings.


Participants have an implicit responsibility to use newly acquired information to improve patient outcomes and their own professional development. The information presented in this activity is not intended to serve as guidelines for the management of patients. The procedures, drugs, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without an assessment of their patient’s condition and possible contraindications and/or dangers in use. , review of applicable manufacturer’s product information and comparison with recommendations from other authorities.

Copyright Statement

This CME simulation activity is licensed to Integritas Communications. Copyright © 2021 Syandus Inc and Integritas Communications. All rights reserved. No part of this simulation activity may be reproduced without the written permission of Integritas Communications and Syandus Inc.

Clinical Resource Center


Comments are closed.